1. Introduction {#s0005}
===============

Leishmaniasis and Chagas disease are known as serious public health problems due to their high mortality rate in countries such as Brazil, since they are directly linked to socioeconomic issues ([@b0065]).

Leishmaniasis is caused by a blood parasite, where its transmission is through the bite of an infected sandfly, where during blood feeding, parasites are inoculated into the skin of the host. Domestic animals serve as reservoirs, especially the house dog and wild ones, but humans have become a possible reservoir due to the organizational changes in cities, and thus, leishmaniasis is no longer just a rural disease ([@b0090]). American cutaneous leishmaniasis has 3 clinical forms, cutaneous, mucocutaneous and diffuse cutaneous. The mucocutaneous one is characterized by lesions that destroy cartilage and mucosal tissues. Visceral leishmaniasis, known as kala azar, is considered the most severe and has symptoms such as hepatosplenomegaly and pancytopenia, and can lead to death depending on the progress of the disease. These 3 forms are caused respectively by *Leishmania brasiliensis* and *Leishmania donovani*, *Leishmania infantum* and *Leishmania chagasi* ([@b0010], [@b0080]).

A major problem with this disease is the lack of vaccines and medicines that are safe and effective, especially for dogs, which have become the main host and cause of major difficulties in controlling the disease, because this animal is found in homes and because they are cherished by humans ([@b0090]).

Chagas disease is caused by the protozoan *Trypanosoma cruzi*, which is transmitted by the triatomine known as the kissing bug, during blood feeding, when it penetrates the skin leaving urine or feces infected with metacyclic trypomastigotes, which infect the host, usually mammals. But this is not the only transmission route, as others have been demonstrated, such as contamination by blood transfusion and organ transplantation and orally by ingestion of the vector, which happens when it is triturated during the preparation of any food ([@b0145]). The symptomatology is diverse, with the most serious problems in the chronic phase with the occurrence of cardiac and hepatic complications, among others ([@b0105]). The treatment of the latter has several limitations, such as being more effective in the acute phase of the disease and causing many side effects ([@b0025]). Because of these factors, the importance of developing new drugs is evident, especially those derived from medicinal plants, due to their wide variety and easy access for people with less purchasing power ([@b0055]).

Because of the tradition of using medicinal plants in Brazil, their pharmacological properties have been arduously explored by Brazilian investigators and more recently by the pharmaceutical industry because of the need to develop new drugs ([@b0035]).

The genus *Stryphnodendron* belongs to the subfamily Mimosoideae and family Leguminosae, which encompasses approximately 64 genera. *Stryphnodendron rotundifolium* Mart is species popularly known as 'barbatimão, barba-de-timão, charãozinho-roxo, casca-da-virgindade, casca-da-mocidade and barbatimão-vermelho" ([@b0130]). The species *S. rotundifolium* Mart., endemic to Chapada do Araripe, is used by much of the population of the Cariri where the bark of this tree is used to treat wounds, sores, gastritis, vaginal inflammation and infections ([@b0095]).

Phytochemical prospecting of *S. rotundifolium* bark extract has been performed, showing the presence of tannin pyrogallics, flavones, flavonols, flavononols, xanthones, chalcones, flavonones and steroids as secondary metabolites in this species ([@b0095]), along with antibacterial and antifungal ([@b0120]), antioxidant ([@b0020]) and antibiotic-modifying ([@b0095]) activity.

Accordingly, the aim of the study was to evaluate the trypanocidal and leishmanicidal activity of the hydroalcoholic extract of the bark of *S. rotundifolium* to determine its therapeutic potential in these conditions, for a possible alternative treatment for patients.

2. Materials and methods {#s0010}
========================

2.1. Botanical material {#s0015}
-----------------------

The plant material of *S. rotundifolium* was collected in Crato, Ceará, Brazil, in March 2011. A voucher specimen of the species is deposited in the Herbarium Dárdaro de Andrade Lima-URCA under No. 4661.

2.2. Preparation of hydroalcoholic extract of the bark of *S. rotundifolium* Mart. (EHCSR) {#s0020}
------------------------------------------------------------------------------------------

The plant material (dry bark of *S. rotundifolium*) was subjected to cold extraction with water and 99.99% ethanol (1:1), and the solvent was removed using a rotary evaporator, resulting in a dry crude extract after lyophilization (EHCSR).

2.3. Preparation of the solution EHCSR {#s0025}
--------------------------------------

EHCSR was dissolved in phosphate buffered saline (PBS, pH 7.2) at a concentration of 1 mg/mL, subsequently giving test concentrations of 500, 250 and 125 μg/mL. The assays were performed in triplicate.

2.4. Quantification of compounds by HPLC-DAD {#s0030}
--------------------------------------------

All chemical agents were of analytical grade. Methanol, acetic acid, gallic acid and caffeic acid were purchased from Merck (Darmstadt, Germany). Catechin, rutin and kaempferol were acquired from Sigma Chemical Co. (St. Louis, MO, USA). High performance liquid chromatography (HPLC-DAD) was performed with the Shimadzu HPLC system (Shimadzu, Kyoto, Japan) and Prominence Auto Sampler (SIL-20A), equipped with Shimadzu LC-20AT reciprocating pumps connected to the degasser DGU 20A5 with integrator CBM 20A, UV--vis detector DAD (diode) SPD-M20A and Software LC solution 1.22 SP1.

Reverse-phase chromatographic analyses were carried out under gradient conditions using a C18 column (4.6 mm × 250 mm) packed with 5-μm diameter particles; the mobile phase was water containing 2% acetic acid (A) and methanol (B), and the composition gradient was: 5% of B until 2 min and changed to 25, 40, 50, 60, 70 and 100% B at 10, 20, 30, 40, 50 and 80 min, respectively, following the method described by [@b0030] with slight modifications. EHCSR was dissolved in ethanol at a concentration of 5 mg/mL and analyzed. The presence of five phenolic compounds was determined, namely catechin, gallic and caffeic acids and the flavonoids rutin and kaempferol. Identification of these compounds was performed by comparing their retention time and UV absorption spectrum with those of commercial standards. The flow rate was 0.6 mL/min and injection volume 40 μL, and the wavelengths used for detection were 257 nm for gallic acid, 280 nm for catechin, 325 nm for caffeic acid and 365 nm for rutin and kaempferol. All samples and mobile phase were filtered through a 0.45-μm membrane filter (Millipore) and then degassed with an ultrasonic bath prior to use. Stock solutions of reference standards were prepared in the HPLC mobile phase at concentrations of 0.020--0.200 mg/mL for kaempferol and rutin and 0.030--0.250 mg/mL for catechin, caffeic and chlorogenic acids. The chromatographic peaks were confirmed by comparing their retention times with those of reference standards and by DAD spectra (200--400 nm). The calibration curves were: gallic acid, *Y* = 12575*x* + 1253.8 (*r* = 0.9999); caffeic acid, *Y* = 11407*x* + 1359.8 (*r* = 0.9996); catechin, *Y* = 11355*x* − 1047.1 (*r* = 0.9968); rutin, *Y* = 12492*x* − 1065.7 (*r* = 0.9997); and kaempferol, *Y* = 14923*x* − 1238.9 (*r* = 0.9997).

2.5. Obtaining parasites and cells {#s0035}
----------------------------------

We used blood cultures of *T. cruzi* epimastigotes and promastigotes of *L. brasiliensis* and *L. infantum.* The epimastigotes were obtained in the exponential growth phase in liver infusion tryptose (LIT) and washed twice in sterile PBS, pH 7.2, with centrifugation at 1500 rpm for 10 min at 4 °C, and the number of parasites was determined in a Neubauer chamber. Afterward, the parasites were suspended in LIT medium supplemented with 10% fetal bovine serum (FBS) (inactivated at 56 °C), adjusted to 5 × 10^6^ epimastigotes/mL, and kept at 4 °C until use.

The promastigotes of *L. brasiliensis* and *L. infantum* were in the exponential growth phase in Schneider medium supplemented with 5% FBS and 2% urine. They were washed twice in sterile PBS, pH 7.2, with centrifugation at 1500 rpm for 10 min at 4 °C, and the number of parasites was determined in a Neubauer chamber. The parasites were then suspended in Schneider medium plus 5% FCS and 2% of urine, adjusted to 5 × 10^6^ promastigotes/mL, and kept at 4 °C until use.

Fibroblasts were grown in minimal essential medium (MEM), supplemented with 10% heat-inactivated FBS, penicillin G (100 U/mL) and streptomycin (100 μg/mL). Cultures were maintained at 37 °C in a humidified 5% CO~2~ atmosphere until use.

2.6. *In vitro* leishmanicidal evaluation {#s0040}
-----------------------------------------

For the evaluation of leishmanicidal activity against the promastigote form, assays were performed in triplicate in 96-well culture plates containing 20 μL of EHCSR at concentrations in descending order, diluted in sterile PBS, pH 7.2, plus 180 μL of the suspension of promastigotes. In the controls, the parasites were incubated in the absence of extract or in the presence of 100 μg/mL pentamidine. After the addition of the natural products, the samples were shaken and incubated at 24 °C for 72 h. The plates were then evaluated visually under a microscope to check for motility of parasites. The results were expressed as a percentage. The assays were carried out in triplicate with the objective of assessing the stability of EHCSR activity and the reproducibility of the results. Pentamidine was used as the reference drug.

2.7. *In vitro* evaluation of trypanocidal {#s0045}
------------------------------------------

The trypanocidal assays against epimastigotes were performed in triplicate in 96-well culture plates containing 20 μL of EHCSR at concentrations in descending order, diluted in sterile PBS, pH 7.2, plus 180 μL of epimastigote suspension. In the control, the parasites were incubated in the absence of extract or in the presence of 100 μg/L Nifurtimox. The plates were then shaken and incubated at 24 °C for 72 h and assessed visually under a microscope to check for motility of parasites. The activity was determined by counting in a Neubauer chamber, followed by statistical evaluation. The results were expressed as a percentage. The assays were carried out in triplicate to assess the stability of the extract activity and reproducibility of the results.

2.8. Evaluation of cytotoxicity {#s0050}
-------------------------------

Murine J477 fibroblasts were adhered to 96-well microdilution plates at a final concentration of 3 × 10^4^ cells/well and incubated at 37 °C in an atmosphere of 5% CO~2~. Subsequently, MEM was removed and 200 μL of EHCSR in different concentrations were added and the plates incubated for another 24 h. Afterward, 20 μL of 2 mM resazurin was added to each well. Plates were incubated for 3 h and the reduction of resazurin was determined by absorbance at 490 and 595 nm. The value of the control (blank) was subtracted. Each concentration was tested in triplicate.

2.9. Statistical analysis {#s0055}
-------------------------

All assays were performed in triplicate and repeated at least once. Half-maximal growth inhibitory concentration (IC~50~) was determined by linear regression using GraphPad Prism Software.

3. Results and discussion {#s0060}
=========================

HPLC fingerprinting of EHCSR revealed the presence of gallic acid (tR = 17.01 min; peak 1), catechin (tR = 24.88 min; peak 2), caffeic acid (tR = 31.62 min; peak 3), rutin (tR = 47.14 min; peak 4) and kaempferol (tR = 58.49 min; peak 5) ([Fig. 1](#f0005){ref-type="fig"}). Thus, HPLC analysis revealed the EHCSR contained flavonoids (rutin and kaempferol), phenolics acids (caffeic acids) and catechin.Figure 1Representative high performance liquid chromatography profile of phenolics and flavonoid composition of the *Stryphnodendron rotundifolium* extract, detection UV was at 325 nm. Results were expressed as mean ± standard deviations (SD) of three determinations. Averages followed by different letters differ by Tukey test at *p* \< 0.005.

An ethnopharmacological study has shown that *S. rotundifolium* is used as a popular medicine by traditional communities in Northeast Brazil. The stem bark of this plant is used especially in the form of a decoction ([@b0035]). Phytochemical prospecting of hydroalcoholic extract of *S. rotundifolium* (HESR) has led to the identification of tannins, pyrogallics, flavones, flavonoids, flavononols, xanthones, chalcones, flavonones and steroids ([@b0095]). Data from the literature show that bark extracts of species of this genus contain tannins and flavonoids ([@b0075], [@b0150]).

The results in [Table 1](#t0005){ref-type="table"} show the effect of the reference drug, pentamidine, on *Leishmania* sp., where IC~50~ = 5.69 μg/mL. [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"} show the results for the anti-promastigote activity against *Leishmania* sp. Against *L. infantum* ([Table 2](#t0010){ref-type="table"}), the four concentrations of EHCSR tested caused a similar percentage of parasite inhibition, around 45%, with an estimated IC~50~ = 1300 μg/mL. *L. brasiliensis* ([Table 3](#t0015){ref-type="table"}) was substantially inhibited only at 1000 μg/mL, where the percentage of the inhibition was 56.38%, yielding an IC~50~ = 987.35 μg/mL.Table 1Results of pentamidine on *Leishmania infantum* promastigotes in the parasitic form (IC~50~ = 5.69 μg/mL).Concentration (μg/mL)% Anti-promastigote (*L. infantum*)% ± standard deviation10093.90.35093.90.12589.20.612.580.60.26.2554.20.33.12515.51.1Table 2Results of EHCSR, on *Leishmania infantum* promastigotes in the parasitic form (IC~50~ = 1338.76 μg/mL).Concentration (μg/mL)% Anti-promastigote (*L. infantum*)% ± standard deviation100047.140.6950045.632.5225040.671.1215043.472.72Table 3Result of EHCSR, on *Leishmania brasiliensis* in parasitic promastigote form (IC~50~ = 987.35 μg/mL).Concentration (μg/mL)% Anti-promastigote (*L. infantum*)% ± standard deviation100056.385.495004.682.062502.851.791502.851.07

According to [@b0125], when more than 50% parasite inhibition is achieved at an extract concentration of 500 μg/mL, the test substance is considered a good inhibitor of parasites. Although EHCSR did not show this level of activity, its potential cannot be ruled out, since its activity came close to the above benchmark, which can be explained by the EHCSR components present, including tannins, flavonoids and phenolic compounds, the main secondary metabolites present in this species ([@b0160]).

The anti-Leishmania effect was the target of a study by [@b0060], who demonstrated that condensed tannins, polyphenols, simple phenolics and tannins possess this activity. In previous studies the antileishmanial activity of extracts of the fruit of *Cocos nucifera* L., rich in polyphenols was evaluated, where a satisfactory effect was obtained with a minimum inhibitory concentration of 10 μg/mL ([@b0085]).

According to [@b0100], the hydroethanolic extract of *Caryocar brasiliense* leaves has antileishmanial activity against the promastigote forms and strong antioxidant activity, corroborating the findings of the present study, because extracts of the genus *Stryphnodendron* have antioxidant activity as already mentioned ([@b0070]), and this was also shown for *S. rotundifolium* by [@b0020]. [@b0165] reported that antioxidant compounds such as flavonoids may have an effect on promastigotes of *Leishmania* sp., where viability was measured by reduction of a tetrazolium salt. [@b0135] reported that treatment with the flavonoid quercetin combined with serum albumin showed increased bioavailability of the flavonoid, proving to be major advantage in promoting its effectiveness against *L. donovani*.

According to [@b0015] crude extracts from plants have a greater leishmanicidal effect against promastigotes, [@b0110] showed that the hydroalcoholic extract of *Chenopodium ambrosioides* leads to a decrease in parasite load in infection with *L. amazonian* in vivo, demonstrating that the extract used in our study possibly possesses these leishmanicidal characteristics due to these factors, and because this is a crude hydroalcoholic extract, as previously used.

[Table 4](#t0020){ref-type="table"} shows the effect of the reference drug chosen, Nifurtimox, on motility of *T. cruzi*. epimastigotes, showing an IC~50~ = 2.20 μg/mL. The trypanocidal activity of EHCSR against epimastigotes ([Table 5](#t0025){ref-type="table"}) showed relevancy at a concentration of 1000 μg/mL, at which there was 82.31% death of parasitic forms. Lower extract concentrations of 250 and 500 μg/mL showed low toxicity, respectively 2.31% and 7.07%, while the lowest concentration of 150 μg/mL had no effect on epimastigotes, and IC~50~ = 748.97 μg/mL was determined. In studies by [@b0050] using the crude extract of the bark of the species *Stryphnodendron adstringens*, which belongs to the same genus of the extract used in this study proved to be effective against the parasite *T. Cruzi* in vivo, almost totally eliminating all parasites found in the blood of animals, demonstrating its effectiveness against it.Table 4Result of Nifurtimox, on *Trypanosoma cruzi* epimastigote form in the parasite (IC~50~ = 20.02 μg/mL).Concentration (μg/mL)% Anti-epimastigote (*T. cruzi*)% ± standard deviation10010000.4650930.6610840.621430.930.5132.500.101.54Table 5Result of EHCSR, against *Trypanosoma cruzi* epimastigote form in the parasite (IC~50~ = 748.97 μg/mL).Concentration (μg/mL)% Anti-epimastigote (*T. cruzi*)% ± standard deviation100082.3112.575007.0712.552502.131.21150012.35

[@b0115] isolated flavanones from *Trixis vauthieri* L. and found that they eliminated about 99% of the parasites in infected blood. [@b0040] isolated a number of substances from *Lychnophora pohlii*, where flavonoids showed considerable trypanocidal activity. [@b0155] demonstrated that flavonoids present in other species of *Lychnophora* were effective against *T. cruzi* in contaminated blood in blood banks. [@b0140] observed the same activity but in vivo. These data are of paramount importance for the present study because of the presence of flavonoids in EHCSR, which shows one of the probable reasons for the trypanocidal effect observed. [@b0005] showed that a xanthone isolated from *Garcinia subellíptica* was active against epimastigote and trypomastigote forms and protozoa of *T. cruzi*; xanthones were also found in EHCSR.

Previous findings support the potential anti-parasitic activity of EHCSR, but one cannot dismiss the importance of the results demonstrating potential host cytotoxicity ([Table 6](#t0030){ref-type="table"}). Concentrations of 500 and 1000 μg/mL, which were the most representative of anti-parasitic activity, also showed very high toxicity in cultured fibroblasts cells, 75.12% and 94.14% respectively, with an IC~50~ = 190.24 μg/mL.Table 6EHCSR cytotoxic activity on fibroblasts (IC~50~ = 190.24 μg/mL).Concentration (μg/mL)% Cytotoxicity% ± standard deviation100094.141.0450075.121.6325062.421.0115043.392.03

Our results demonstrated a dose-dependent effect, but limited because bioavailability was not considered. Several studies have shown the contribution of *in vitro* assays for in vivo applicability ([@b0045]). These methods will therefore be highly useful for future preclinical and clinical studies. These results then provide important knowledge to explore the potential of EHCSR in the treatment of parasitic infections as *T. cruz* or *Leishmania*.

4. Conclusion {#s0065}
=============

We found that the hydroalcoholic extract of *S. rotundifolium* bark (EHCSR) had better activity against *T. cruzi* in comparison with two *Leishmania* species. However, the results did not show clinical significance with regard to anti-parasitic activity. EHCSR showed a significant cytotoxicity against fibroblast cells, indicating limits to its use in a systemic way. This plant appears to be promising for the development of herbal products and/or new drugs with antiparasitary actions, but, in vivo assay is necessary for drug evaluation.
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